Capstan Therapeutics
Signal active
Organization
Contact Information
Overview
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2021
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Capstan Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $12.2B in funding across 36 round(s). With a team of 101-250 employees, Capstan Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Capstan Therapeutics, raised $175.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
15
Lead Investors
0
Total Funding Amount
$340.0M
Details
3
Capstan Therapeutics has raised a total of $340.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 102.0M | ||
| 2021 | Seed | 63.0M | ||
| 2024 | Early Stage Venture | 175.0M |
Investors
Capstan Therapeutics is funded by 35 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| RA Capital Management | - | FUNDING ROUND - RA Capital Management | 175.0M |
| Mubadala Capital Ventures | - | FUNDING ROUND - Mubadala Capital Ventures | 175.0M |
| Capstan Therapeutics | - | FUNDING ROUND - Capstan Therapeutics | 175.0M |
| Bristol-Myers Squibb | - | FUNDING ROUND - Bristol-Myers Squibb | 175.0M |
Recent Activity
There is no recent news or activity for this profile.